SCHEMBL19968037

SCHEMBL19968037

Cc1nc(Nc2ncc(F)c(-c3cc(F)c4nc(C)n(C(C)C)c4c3)n2)ccc1C=O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 20/20 0.64
CDK2 P24941 17/20 0.64
CDK6 Q00534 17/20 0.64
CDK1 P06493 10/20 0.64
CDK9 P50750 6/20 0.64
CDK7 P50613 5/20 0.64
CCNB1 P14635 6/20 0.61
CCNE1 P24864 6/20 0.61
CIT O14578 1/20 0.61
GAK O14976 1/20 0.61
DYRK3 O43781 1/20 0.61
CCNT1 O60563 1/20 0.61
STK16 O75716 1/20 0.61
CCNK O75909 1/20 0.61
STK10 O94804 1/20 0.61
PRKD3 O94806 1/20 0.61
ABCB11 O95342 1/20 0.61
MAP4K4 O95819 1/20 0.61
CCNE2 O96020 1/20 0.61
EGFR P00533 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29405233 1.00 CDK4 (0.64) CDK4CDK2CDK6CDK1CDK9
SCHEMBL28488751 0.94 CDK4 (0.63) CDK4CDK2CDK6CDK1CDK9
SCHEMBL29404659 0.94 CDK4 (0.63) CDK4CDK2CDK6CDK1CDK9
SCHEMBL29402884 0.89 CDK4 (0.57) CDK4CDK2CDK6CDK1CDK9
SCHEMBL19968025 0.89 CDK4 (0.57) CDK4CDK2CDK6CDK1CDK9
SCHEMBL19968048 0.89 CDK4 (0.68) CDK4CDK2CDK6CDK1CDK9
SCHEMBL21658989 0.88 CDK4 (0.69) CDK4CDK2CDK6CDK1CDK9
SCHEMBL29894133 0.88 CDK4 (0.69) CDK4CDK2CDK6CDK1CDK9
SCHEMBL28560761 0.87 CDK4 (0.61) CDK4CDK2CDK6CDK1CDK9
SCHEMBL19968027 0.85 CDK4 (0.68) CDK4CDK2CDK6CDK1CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115040523-A Use of PI3K inhibitors in combination with estrogen receptor antagonists for the treatment of neoplastic diseases 上海翰森生物医药科技有限公司 2022-09-13 CN disclosed
CN-112225724-B Benzimidazole compound kinase inhibitor and preparation method and application thereof 江苏豪森药业集团有限公司 2022-04-29 CN disclosed
CN-112250669-B Benzimidazole compound kinase inhibitor and preparation method and application thereof 江苏豪森药业集团有限公司 2022-02-25 CN disclosed
CN-112250669-A Benzimidazole compound kinase inhibitor and preparation method and application thereof 江苏豪森药业集团有限公司 2021-01-22 CN disclosed
CN-112225724-A Benzimidazole compound kinase inhibitor and preparation method and application thereof 江苏豪森药业集团有限公司 2021-01-15 CN disclosed
CN-109963842-B Benzimidazole compound kinase inhibitor and preparation method and application thereof 江苏豪森药业集团有限公司 2020-11-03 CN disclosed
WO-2018045956-A1 BENZIMIDAZOLE COMPOUND KINASE INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 江苏豪森药业集团有限公司 2018-03-15 WO disclosed